BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28126652)

  • 1. A de novo mutation in the X-linked PAK3 gene is the underlying cause of intellectual disability and macrocephaly in monozygotic twins.
    Hertecant J; Komara M; Nagi A; Al-Zaabi O; Fathallah W; Cui H; Yang Y; Eng CM; Al Sorkhy M; Ghattas MA; Al-Gazali L; Ali BR
    Eur J Med Genet; 2017 Apr; 60(4):212-216. PubMed ID: 28126652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel
    Iida A; Takano K; Takeshita E; Abe-Hatano C; Hirabayashi S; Inaba Y; Kosugi S; Kamatani Y; Momozawa Y; Kubo M; Nakagawa E; Inoue K; Goto YI
    Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31444167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures.
    Horn S; Au M; Basel-Salmon L; Bayrak-Toydemir P; Chapin A; Cohen L; Elting MW; Graham JM; Gonzaga-Jauregui C; Konen O; Holzer M; Lemke J; Miller CE; Rey LK; Wolf NI; Weiss MM; Waisfisz Q; Mirzaa GM; Wieczorek D; Sticht H; Abou Jamra R
    Brain; 2019 Nov; 142(11):3351-3359. PubMed ID: 31504246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Molecular Aspects of the Neurodevelopmental Disorder Associated with PAK3 Perturbation.
    Pascolini G; Gaudioso F; Passarelli C; Novelli A; Di Giosaffatte N; Majore S; Grammatico P
    J Mol Neurosci; 2021 Dec; 71(12):2474-2481. PubMed ID: 34227036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability.
    Muthusamy B; Selvan LDN; Nguyen TT; Manoj J; Stawiski EW; Jaiswal BS; Wang W; Raja R; Ramprasad VL; Gupta R; Murugan S; Kadandale JS; Prasad TSK; Reddy K; Peterson A; Pandey A; Seshagiri S; Girimaji SC; Gowda H
    OMICS; 2017 May; 21(5):295-303. PubMed ID: 28481730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.
    Duarte K; Heide S; Poëa-Guyon S; Rousseau V; Depienne C; Rastetter A; Nava C; Attié-Bitach T; Razavi F; Martinovic J; Moutard ML; Cherfils J; Mignot C; Héron D; Barnier JV
    Neurobiol Dis; 2020 Mar; 136():104709. PubMed ID: 31843706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel PAK3 gene missense variant associated with two Chinese siblings with intellectual disability: a case report.
    Qian Y; Wu B; Lu Y; Zhou W; Wang S; Wang H
    BMC Med Genet; 2020 Feb; 21(1):31. PubMed ID: 32050918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical assessment of five patients with BRWD3 mutation at Xq21.1 gives further evidence for mild to moderate intellectual disability and macrocephaly.
    Grotto S; Drouin-Garraud V; Ounap K; Puusepp-Benazzouz H; Schuurs-Hoeijmakers J; Le Meur N; Chambon P; Fehrenbach S; van Bokhoven H; Frébourg T; de Brouwer AP; Saugier-Veber P
    Eur J Med Genet; 2014 Apr; 57(5):200-6. PubMed ID: 24462886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel PAK1 variant causative of neurodevelopmental disorder with postnatal macrocephaly.
    Ohori S; Mitsuhashi S; Ben-Haim R; Heyman E; Sengoku T; Ogata K; Matsumoto N
    J Hum Genet; 2020 May; 65(5):481-485. PubMed ID: 32005903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of a child with X-linked intellectual disability due to a maternal de novo splicing variant of the PAK3 gene].
    Wang C; Qiu X; Hu H; Jin B; Cheng Y; Zhao Y; Zhou C; Ma L; Zhang Y; Zheng F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jul; 40(7):865-870. PubMed ID: 37368392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-Activated Kinase 3 (PAK3)-Related Intellectual Disability Associated with Combined Immunodeficiency: A Case Report.
    Almutairi O; Almutairi HA; Al Rushood M
    Am J Case Rep; 2021 May; 22():e930966. PubMed ID: 34014906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.
    Bienvenu T; des Portes V; McDonell N; Carrié A; Zemni R; Couvert P; Ropers HH; Moraine C; van Bokhoven H; Fryns JP; Allen K; Walsh CA; Boué J; Kahn A; Chelly J; Beldjord C
    Am J Med Genet; 2000 Aug; 93(4):294-8. PubMed ID: 10946356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A splice site mutation in HERC1 leads to syndromic intellectual disability with macrocephaly and facial dysmorphism: Further delineation of the phenotypic spectrum.
    Aggarwal S; Bhowmik AD; Ramprasad VL; Murugan S; Dalal A
    Am J Med Genet A; 2016 Jul; 170(7):1868-73. PubMed ID: 27108999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK1 c.1409 T > a (p. Leu470Gln) de novo variant affects the protein kinase domain, leading to epilepsy, macrocephaly, spastic quadriplegia, and hydrocephalus: Case report and review of the literature.
    Corriveau ML; Amaya SI; Koebel MC; Lerma VC; Michener SL; Turner A; Schultz RJ; Seto ES; Diaz-Medina GE; Craigen WJ; Swann JW; Xue M; Chao HT
    Am J Med Genet A; 2023 Jun; 191(6):1619-1625. PubMed ID: 36905087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis.
    Castillon C; Gonzalez L; Domenichini F; Guyon S; Da Silva K; Durand C; Lestaevel P; Vaillend C; Laroche S; Barnier JV; Poirier R
    Hum Mol Genet; 2020 Jul; 29(12):1950-1968. PubMed ID: 31943058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAK3 related mental disability: further characterization of the phenotype.
    Peippo M; Koivisto AM; Särkämö T; Sipponen M; von Koskull H; Ylisaukko-oja T; Rehnström K; Froyen G; Ignatius J; Järvelä I
    Am J Med Genet A; 2007 Oct; 143A(20):2406-16. PubMed ID: 17853471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further delineation of the phenotype of PAK3-associated x-linked intellectual disability: Identification of a novel missense mutation and review of literature.
    Nagy D; Farkas K; Armengol L; Segura M; Esi Zodanu GK; Csányi B; Zimmermann A; Vámos B; Széll M
    Eur J Med Genet; 2020 Apr; 63(4):103800. PubMed ID: 31678216
    [No Abstract]   [Full Text] [Related]  

  • 20. A mutation in PAK3 with a dual molecular effect deregulates the RAS/MAPK pathway and drives an X-linked syndromic phenotype.
    Magini P; Pippucci T; Tsai IC; Coppola S; Stellacci E; Bartoletti-Stella A; Turchetti D; Graziano C; Cenacchi G; Neri I; Cordelli DM; Marchiani V; Bergamaschi R; Gasparre G; Neri G; Mazzanti L; Patrizi A; Franzoni E; Romeo G; Bordo D; Tartaglia M; Katsanis N; Seri M
    Hum Mol Genet; 2014 Jul; 23(13):3607-17. PubMed ID: 24556213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.